ABSTRACT
INTRODUCTION

49
Advancing age is a primary risk factor for the development of numerous chronic 50 degenerative diseases, which are the leading causes of morbidity and mortality in the United
51
States and other developed nations (20, 30, 41) . A key event underlying the etiology of many 52 chronic age-related disorders is stiffening of the large elastic arteries, specifically the aorta.
53
Elevated aortic stiffness increases the pulsatile shear and pressure experienced by the heart, 54 blood vessels and other organs, which can have numerous pathophysiological effects 55 contributing to the development of disease (23, 32, 34, 35, 38, 62) . Indeed, aortic pulse-wave 56 velocity (aPWV), the gold-standard measure of arterial stiffness, is a strong independent risk 57 factor for incident cardiovascular events among older adults (34, 50) and also predicts the 58 development of chronic kidney disease, stroke, cognitive impairment, and Alzheimer's Disease
59
(2, 7, 18, 21, 43, 53). Current demographic trends forecast a major increase in the number of 60 older adults in the coming decades which will be accompanied by attendant increases in disease 61 prevalence and health care costs (19, 22, 56) . As such, a top biomedical research priority is to 62 identify strategies that prevent or reverse aortic stiffening with advancing age, as this may help 63 prevent, reduce, or delay the development of multiple common disorders of aging.
64
A key mechanism underlying the development of age-related arterial stiffening may be 
9
To examine the potential role of changes in blood pressure to treatment-related 139 differences in aPWV, we assessed systolic and diastolic blood pressure at baseline and following 140 4 weeks of MitoQ or normal drinking water consumption using the CODA non-invasive tail-cuff 141 system as previously described (11, 28 rings from the thoracic region (dissected free of surrounding connective tissue) were used to 149 assess intrinsic aortic stiffness via wire myography, as described previously by our laboratory (6, 150 10, 14, 28). Aortic rings were loaded into heated myograph chambers (DMT, Inc.) with calcium-151 free phosphate buffered saline. Following three cycles of pre-stretching, ring diameter was 152 increased to achieve 1mN force and then incrementally stretched by ~10% every 3 minutes until 153 failure. The force corresponding to each stretching interval was recorded and used to calculate 154 stress and strain, defined as follows:
Collagen Elastic Modulus
164
When aortic rings are subjected to stress-strain testing, the region of the stress-strain 165 curve corresponding to the highest forces represents the stretching of predominately collagen 166 fibers (25, 47). The elastic modulus of the collagen-dominant region was determined as the slope 167 of the linear regression fit to the final four points of the stress-strain curve, as described 
Elastin Elastic Modulus
171
During stress-strain testing in aortic rings, the region of the stress-strain curve 172 corresponding to the stretching of exclusively elastin fibers is a lower-force region prior to after a 10-minute or 1-minute exposure to diaminobenzidine (elastin and collagen, respectively).
220
Stained aortic sections were imaged using a Nikon Eclipse TS100 photomicroscope 221 under identical conditions. Quantification of the integrated density of the stain was performed 222 using ImageJ software by a single investigator blinded to the group assignment of each sample.
223
Collagen-I expression was assessed in the whole artery sections, comprising both the medial and 224 adventitial layers, whereas elastin expression was assessed in the medial layer, the primary site 225 of age-related changes in elastin expression (9, 10). Integrated density values from 4 sections 226 were averaged to provide a single value for each protein per aorta, which are expressed relative 227 to the mean of the young control group.
228
Statistical Analysis
230
All statistical analyses were performed using SPSS 23.0 software (Armonk, NY, USA).
231
Data were first assessed for outliers and normality/homogeneity of variance. Between-group 232 differences in morphological characteristics and aortic protein expression (Western blot,
233
immunohistochemistry, multiplex ELISA) were determined using one-way analysis of variance.
234
Between-group differences in elastic modulus (collagen and elastin regions) were determined 235 using a linear mixed model with age (young versus old) and treatment (control versus MitoQ) as 236 factors, whereas within-group differences in aPWV and blood pressure were examined using a 237 linear mixed model that also included a repeated factor (pre-versus post-intervention period).
238
When a significant main effect was observed, Fisher's least significant difference post-hoc tests
239
were performed to determine specific pair-wise differences. 
RESULTS
242
MitoQ consumption across the 4-week treatment period was similar to our previous 243 report and not different between young and old mice (~1 mmol/day; (15)). Select morphological 244 characteristics and blood pressure are shown in Table 1 . Consistent with our previous study (15),
245
4 weeks of MitoQ treatment did not influence overall morphology; although there were age-246 associated differences in body mass, heart mass, and quadriceps mass, these were not different 247 between mice receiving MitoQ versus normal drinking water. There were no age-or treatment-248 related differences in aortic diameter or systolic and diastolic blood pressure. significantly decreased aPWV in old mice to levels similar to young mice following the 255 intervention period. MitoQ treatment had no effect on aPWV in young mice. These results
256
indicate that 4 weeks of MitoQ treatment specifically reverses aortic stiffening in old mice. 
Ex-vivo aortic stiffness-collagen-and elastin-mediated mechanical properties of aortic rings 269
The elastic modulus of the collagen region of stress-strain curves was significantly 270 greater in old control versus young control mice ( Figure 3A) , whereas the elastic modulus of the was greater than that of old control mice (p=0.07).
292
Together with our observations of intrinsic mechanical properties, these results suggest 293 that the reduction in in vivo aortic stiffening in old mice following MitoQ treatment was 294 mediated not by effects on aortic collagen, but possibly by partial preservation of elastin. 
Conclusion
401
In conclusion, the present study demonstrates that late-life treatment with a mitochondria-402 targeted antioxidant, MitoQ, effectively reverses aortic stiffening in the setting of primary aging.
403
Our results suggest that this effect is mediated at least partially by attenuation/reversal of the Aortic rings were incrementally stretched until tissue failure, as described in the Methods 643 section, and the tension (stress, kPa) corresponding to each stretch was plotted against strain
644
(change in length relative to resting length) to generate a stress-strain curve. The elastic modulus 645 of the region of the curve corresponding to collagen fiber stretching was determined as the slope mechanical properties but has no effect on collagen-mediated intrinsic mechanical stiffness.
655 656
